The South Korean news agency Yonhap News Agency reported that the immunization program for special education lecturers and kindergarten, elementary, middle and high school teachers that began this Thursday will also be suspended.
MADRID (EUROPA PRESS)-South Korea on Wednesday decided to suspend the administration of the covid-19 vaccine developed by AstraZeneca and Oxford for people under the age of 60 because the authorities are concerned about the vaccine’s relationship with thrombotic events.
In addition, according to information collected by the Korea News Agency (Yonhap), the vaccination program for special education lecturers and teachers in kindergarten, elementary school, middle school and high school that started this Thursday will also be suspended.
The South Korean authorities’ decision was made before the European Medicines Agency (EMA) announced a possible link between AstraZeneca’s drugs and thrombosis, although an official on Tuesday confirmed the “link” between the vaccine and these events. Last month, European authorities have concluded that the drug is “safe and effective.”
So far, more than 106,000 people in South Korea have been infected with COVID-19, including more than 1,700 deaths from the disease.